MPM BioImpact LLC - Significant Ownership

Signature - Title
/s/ Christopher Wolf - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MPM BioImpact LLC.

Significant Ownership of MPM BioImpact LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 16.4% $8.97M 14.7M MPM BioImpact LLC Dec 31, 2024
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.001 per share 4.1% $14.6M -$7.66M 5.62M -34.4% MPM BioImpact LLC Jun 30, 2025

Schedules 13D/G Reported by MPM BioImpact LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.